Status:
UNKNOWN
Study of microRNAs as a Diagnostic Tool for HCV-related Hepatocellular Carcinoma
Lead Sponsor:
HMHamed
Conditions:
miRna in HCC
Eligibility:
All Genders
20-80 years
Brief Summary
The aim of this work is to study the role of circulating miRNAs in diagnosis of HCV related hepatocellular carcinoma.
Detailed Description
Early diagnosis of hepatocellular carcinoma can significantly improve the overall survival of HCC patients, currently available diagnostic markers are still inadequate and limited by their low sensiti...
Eligibility Criteria
Inclusion
- RNA extraction and quantitative Real-Time PCR analysis
- Diagnosis of HCV will be based on detection of anti-HCV antibodies
- Diagnosis of liver cirrhosis will be based on ultrasonography, biochemically and elastography when available
- Diagnosis of HCC will be based on ultrasonography, the typical criteria in triphasic multislice CT scan
Exclusion
- HBV or autoimmune or metabolic liver disease
- serological evidence of human immunodeficiency virus (HIV) infection
- malignancy in other organs
- After intervention in treatment of hepatocellular carcinoma
Key Trial Info
Start Date :
February 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03429530
Start Date
February 15 2018
End Date
March 1 2019
Last Update
February 12 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.